Lancelotta RL

Center for Psychedelic Drug Research and Education, College of Social Work, The Ohio State University, Columbus, OH, USA.

2 preprints · 4 papers · ORCID

PreprintDMT

5-MeO-DMT Use in Humans: A Scoping Review of Peer-Reviewed Research

Esposito M, Bernal AMO, Davis AK +1

Europe PMC2026
ArticleDMT

Reactivations Associated with the Use of 5-MeO-DMT Among Spanish-Speaking Individuals: Prevalence, Predictors, and Emotional Valence.

Ortiz Bernal AM, Raison CL, Lancelotta RL +3

Europe PMC2025
ArticlePsilocybin

Study protocol of an open-label proof-of-concept trial examining the safety and clinical efficacy of psilocybin-assisted therapy for veterans with PTSD.

Davis AK, Levin AW, Nagib PB +2

Europe PMC2023
ArticleDMT

Reactivations after 5-methoxy-N,N-dimethyltryptamine use in naturalistic settings: An initial exploratory analysis of the phenomenon's predictors and its emotional valence.

Ortiz Bernal AM, Raison CL, Lancelotta RL +1

Europe PMC2022
PreprintPsilocybin

A Meta-Analysis of Placebo-Controlled Trials of Psychedelic-Assisted Therapy

Luoma JB, Chwyl C, Bathje G +2

Europe PMC2020
ArticleDMT

Use of Benefit Enhancement Strategies among 5-Methoxy-N,N-Dimethyltryptamine (5-MeO-DMT) Users: Associations with Mystical, Challenging, and Enduring Effects.

Lancelotta RL, Davis AK

Europe PMC2020